Judge Won't Revive FCA Medicaid Case Against Allergan, Novo

Law360, New York (November 20, 2012, 1:36 PM EST) -- A Pennsylvania federal judge Friday refused to revive False Claims Act allegations accusing Allergan Inc., Novo Nordisk Inc. and other pharmaceutical companies of defrauding Medicaid by underreporting their average manufacturer prices, saying a request for altered judgment was filed too late.

U.S. District Judge Eduardo C. Robreno concluded the altered judgment request was filed improperly more than 14 days after a July ruling largely wiped out the case of relator and pharmacist Ronald J. Streck, who has accused drug firms of concealing price increases that would have...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.